Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky.
Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California.
Environ Health Perspect. 2021 Dec;129(12):127001. doi: 10.1289/EHP9262. Epub 2021 Dec 1.
BACKGROUND: Exposure to plastic-associated endocrine disrupting chemicals (EDCs) has been associated with an increased risk of cardiovascular disease (CVD) in humans. However, the underlying mechanisms for this association are unclear. Many EDCs have been shown to function as ligands of the nuclear receptor pregnane X receptor (PXR), which functions as xenobiotic sensor but also has pro-atherogenic effects . OBJECTIVE: We sought to investigate the contribution of PXR to the adverse effects dicyclohexyl phthalate (DCHP), a widely used phthalate plasticizer, on lipid homeostasis and CVD risk factors. METHODS: Cell-based assays, primary organoid cultures, and PXR conditional knockout and PXR-humanized mouse models were used to investigate the impact of DCHP exposure on PXR activation and lipid homeostasis and . Targeted lipidomics were performed to measure circulating ceramides, novel predictors for CVD. RESULTS: DCHP was identified as a potent PXR-selective agonist that led to higher plasma cholesterol levels in wild-type mice. DCHP was then demonstrated to activate intestinal PXR to elicit hyperlipidemia by using tissue-specific PXR-deficient mice. Interestingly, DCHP exposure also led to higher circulating ceramides in a PXR-dependent manner. DCHP-mediated PXR activation stimulated the expression of intestinal genes mediating lipogenesis and ceramide synthesis. Given that PXR exhibits considerable species-specific differences in receptor pharmacology, PXR-humanized mice were also used to replicate these findings. DISCUSSION: Although the adverse health effects of several well-known phthalates have attracted considerable attention, little is known about the potential impact of DCHP on human health. Our studies demonstrate that DCHP activated PXR to induce hypercholesterolemia and ceramide production in mice. These results indicate a potentially important role of PXR in contributing to the deleterious effects of plastic-associated EDCs on cardiovascular health in humans. Testing PXR activation should be considered for risk assessment of phthalates and other EDCs. https://doi.org/10.1289/EHP9262.
背景:接触与塑料相关的内分泌干扰化学物质(EDCs)已与人类心血管疾病(CVD)风险增加相关。然而,这种关联的潜在机制尚不清楚。许多 EDC 已被证明可作为核受体孕烷 X 受体(PXR)的配体发挥作用,PXR 作为外源性物质传感器,也具有促动脉粥样硬化作用。 目的:我们试图研究 PXR 对广泛使用的邻苯二甲酸二环己酯(DCHP)这种塑料增塑剂的不良影响在脂质稳态和 CVD 风险因素中的贡献。 方法:使用基于细胞的测定、原代类器官培养以及 PXR 条件性敲除和 PXR 人源化小鼠模型,研究 DCHP 暴露对 PXR 激活和脂质稳态的影响。进行靶向脂质组学以测量循环神经酰胺,这是 CVD 的新预测因子。 结果:鉴定出 DCHP 是一种有效的 PXR 选择性激动剂,可导致野生型小鼠的血浆胆固醇水平升高。然后使用组织特异性 PXR 缺陷型小鼠证明,DCHP 通过激活肠道 PXR 引起高脂血症。有趣的是,DCHP 暴露还以 PXR 依赖性方式导致循环神经酰胺升高。DCHP 介导的 PXR 激活刺激了介导脂肪生成和神经酰胺合成的肠道基因的表达。鉴于 PXR 在受体药理学方面具有相当大的物种特异性差异,还使用 PXR 人源化小鼠来复制这些发现。 讨论:尽管几种知名邻苯二甲酸酯的不良健康影响引起了广泛关注,但对 DCHP 对人类健康的潜在影响知之甚少。我们的研究表明,DCHP 激活 PXR 以在小鼠中诱导高胆固醇血症和神经酰胺产生。这些结果表明 PXR 在促进与塑料相关的 EDC 对人类心血管健康的有害影响方面可能具有重要作用。测试 PXR 激活应考虑用于邻苯二甲酸酯和其他 EDC 的风险评估。
Environ Health Perspect. 2021-12
Mol Endocrinol. 2015-5
J Am Heart Assoc. 2014-4-22
Toxicol Appl Pharmacol. 2004-9-15
Biochim Biophys Acta. 2016-9
Arch Dermatol Res. 2025-2-3
Front Endocrinol (Lausanne). 2024
Lipids Health Dis. 2024-4-29
Arch Toxicol. 2023-11
Trends Mol Med. 2018-11-23
Toxicology. 2019-1-1
Int J Hyg Environ Health. 2018-6-13
Arterioscler Thromb Vasc Biol. 2018-8